Everett E Vokes Selected Research

Everett E Vokes Research Topics

Disease

121	Neoplasms (Cancer) 11/2021 - 02/2001
70	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 02/2001
53	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 07/2002
38	Squamous Cell Carcinoma of Head and Neck 01/2022 - 05/2003
31	Leukemia 07/2017 - 02/2001
25	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 03/2004
21	Lung Neoplasms (Lung Cancer) 01/2022 - 08/2003
20	Disease Progression 01/2022 - 02/2003
14	Fatigue 11/2020 - 01/2004
13	Neutropenia 11/2020 - 04/2004
11	Diarrhea 10/2019 - 01/2004
9	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2004
9	Malignant Mesothelioma 11/2020 - 10/2008
7	Anemia 11/2020 - 05/2003
7	Hypertension (High Blood Pressure) 10/2019 - 10/2008
7	Thrombocytopenia (Thrombopenia) 01/2017 - 10/2002
7	Hemorrhage 01/2017 - 01/2004
7	Exanthema (Rash) 01/2017 - 01/2004
6	Colorectal Neoplasms (Colorectal Cancer) 06/2012 - 07/2004
5	Adenocarcinoma 03/2014 - 08/2004
5	Esophageal Neoplasms (Esophageal Cancer) 01/2013 - 02/2001
5	Weight Loss (Weight Reduction) 09/2010 - 01/2006
4	Carcinoma (Carcinomatosis) 01/2021 - 01/2004
4	Mucositis 01/2017 - 08/2004
4	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2016 - 09/2003
4	Carcinogenesis 03/2014 - 08/2003
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2014 - 10/2009
4	Esophagitis 01/2013 - 10/2002
4	Nausea 06/2012 - 01/2010
4	Pancreatic Neoplasms (Pancreatic Cancer) 02/2012 - 11/2005
4	Thrombosis (Thrombus) 11/2011 - 04/2008
4	Mesothelioma 03/2011 - 06/2006
3	Oropharyngeal Neoplasms 01/2022 - 07/2007
3	Pneumonia (Pneumonitis) 01/2022 - 09/2008
3	Tongue Neoplasms (Tongue Neoplasm) 01/2018 - 01/2010
3	Body Weight (Weight, Body) 11/2016 - 07/2015
3	Dehydration (Water Stress) 01/2013 - 09/2008
3	Renal Cell Carcinoma (Grawitz Tumor) 05/2012 - 01/2004
3	Vomiting 12/2011 - 09/2008
3	Prostatic Neoplasms (Prostate Cancer) 07/2011 - 05/2004

Drug/Important Bio-Agent (IBA)

26	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 02/2001
25	ErbB Receptors (EGF Receptor)IBA 11/2019 - 05/2003
24	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 10/2002
21	PlatinumIBA 01/2022 - 03/2006
19	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 02/2001
14	NivolumabIBA 01/2022 - 07/2015
14	Cetuximab (Erbitux)FDA Link 01/2021 - 02/2004
13	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2011
13	Docetaxel (Taxotere)FDA Link 01/2021 - 02/2001
12	Fluorouracil (Carac)FDA LinkGeneric 01/2016 - 01/2003
11	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 04/2004
11	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2016 - 01/2003
10	Bevacizumab (Avastin)FDA Link 10/2019 - 11/2005
10	Etoposide (VP 16)FDA LinkGeneric 10/2019 - 03/2004
10	Gemcitabine FDA Link 07/2012 - 02/2001
9	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2019 - 01/2004
9	Proteins (Proteins, Gene)FDA Link 03/2014 - 02/2007
9	Phosphotransferases (Kinase)IBA 03/2014 - 11/2005
8	Gefitinib (Iressa)FDA Link 09/2012 - 05/2003
8	Tyrosine Kinase InhibitorsIBA 06/2012 - 01/2004
7	Pemetrexed (MTA)FDA Link 11/2020 - 01/2007
6	Pharmaceutical PreparationsIBA 01/2020 - 01/2004
6	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2015 - 08/2005
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 09/2009
5	veliparibIBA 11/2021 - 07/2011
5	Sunitinib (Sutent)FDA Link 01/2017 - 10/2010
5	Biological ProductsIBA 02/2015 - 02/2003
5	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2015 - 01/2011
4	Monoclonal AntibodiesIBA 01/2018 - 08/2005
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2017 - 08/2003
4	tyrosine receptor (receptor, tyrosine)IBA 03/2014 - 02/2007
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2012 - 12/2004
4	Vinorelbine (Navelbine)FDA LinkGeneric 10/2002 - 02/2001
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021 - 07/2011
3	ElectrolytesIBA 01/2020 - 01/2004
3	ParaffinIBA 01/2020 - 01/2010
3	Formaldehyde (Formol)FDA Link 01/2020 - 01/2010
3	Celecoxib (Celebrex)FDA Link 07/2017 - 02/2008
3	Methotrexate (Mexate)FDA LinkGeneric 01/2017 - 04/2009
3	CrizotinibIBA 12/2015 - 04/2009
3	LigandsIBA 10/2015 - 12/2008
3	Proto-Oncogene Proteins c-metIBA 02/2014 - 12/2008
3	Sorafenib (BAY 43-9006)FDA Link 01/2013 - 04/2010
3	Dasatinib (BMS 354825)FDA Link 06/2012 - 03/2010
3	TOR Serine-Threonine KinasesIBA 05/2012 - 06/2010
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 03/2011 - 10/2008
3	Protein Kinase CIBA 03/2011 - 02/2003
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2011 - 05/2004

Therapy/Procedure

73	Therapeutics 01/2022 - 07/2002
70	Drug Therapy (Chemotherapy) 01/2022 - 02/2001
50	Radiotherapy 01/2021 - 02/2001
50	Chemoradiotherapy 01/2021 - 10/2002
29	Induction Chemotherapy 01/2022 - 02/2001
8	Re-Irradiation 10/2011 - 03/2005
5	Adjuvant Chemotherapy 01/2022 - 11/2006
5	Immunotherapy 10/2021 - 01/2017
4	Combined Modality Therapy 01/2019 - 08/2003
4	Neck Dissection (Radical Neck Dissection) 11/2009 - 05/2004
3	Drug Tapering 01/2022 - 08/2004
3	Conformal Radiotherapy 11/2011 - 05/2008